Bacteriome and mycobiome dysbiosis in oral mucosal dysplasia and oral cancer.
bacteriome
dysbiosis
microbiome
mycobiome
oral cancer
oral candidiasis
oral dysplasia
oral medicine
oral mucosa
oral pathology
Journal
Periodontology 2000
ISSN: 1600-0757
Titre abrégé: Periodontol 2000
Pays: Denmark
ID NLM: 9313276
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
revised:
13
02
2024
received:
12
12
2023
accepted:
17
02
2024
medline:
19
3
2024
pubmed:
19
3
2024
entrez:
19
3
2024
Statut:
aheadofprint
Résumé
It has long been considered that the oral microbiome is tightly connected to oral health and that dysbiotic changes can be detrimental to the occurrence and progression of dysplastic oral mucosal lesions or oral cancer. Improved understanding of the concepts of microbial dysbiosis together with advances in high-throughput molecular sequencing of these pathologies have charted in greater microbiological detail the nature of their clinical state. This review discusses the bacteriome and mycobiome associated with oral mucosal lesions, oral candidiasis, and oral squamous cell carcinoma, aiming to delineate the information available to date in pursuit of advancing diagnostic and prognostic utilities for oral medicine.
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : KI/SLL Styrgruppen för Odontologisk Forskning (SOF)
ID : FoUI-978687
Organisme : Vetenskapsrådet
ID : 2022-01014
Informations de copyright
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Ng E, Tay JRH, Balan P, et al. Metagenomic sequencing provides new insights into the subgingival bacteriome and aetiopathology of periodontitis. J Periodontal Res. 2021;56(2):205-218.
Proctor DM, Shelef KM, Gonzalez A, et al. Microbial biogeography and ecology of the mouth and implications for periodontal diseases. Periodontol 2000. 2020;82(1):26-41.
Mark Welch JL, Rossetti BJ, Rieken CW, Dewhirst FE, Borisy GG. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci USA. 2016;113(6):E791-E800.
Bostanci N, Grant M, Bao K, et al. Metaproteome and metabolome of oral microbial communities. Periodontol 2000. 2021;85(1):46-81.
Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745-759.
Bukhari AF, Farag AM, Treister NS. Chronic oral lesions. Dermatol Clin. 2020;38(4):451-466.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386.
Jansen L, Buttmann-Schweiger N, Listl S, et al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol. 2018;76:8-15.
Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65(5):401-421.
Virchow R. An address on the value of pathological experiments. Br Med J. 1881;2(1075):198-203.
Hubbers CU, Akgul B. HPV and cancer of the oral cavity. Virulence. 2015;6(3):244-248.
Adler I, Muino A, Aguas S, et al. Helicobacter pylori and oral pathology: relationship with the gastric infection. World J Gastroenterol. 2014;20(29):9922-9935.
Anand PS, Nandakumar K, Shenoy KT. Are dental plaque, poor oral hygiene, and periodontal disease associated with Helicobacter pylori infection? J Periodontol. 2006;77(4):692-698.
Meng X, Wang Q, He C, et al. An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma. J Oral Pathol Med. 2016;45(1):17-22.
Devoy C, Flores Bueso Y, Tangney M. Understanding and harnessing triple-negative breast cancer-related microbiota in oncology. Front Oncol. 2022;12:1020121.
Lamont RJ, Fitzsimonds ZR, Wang H, Gao S. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma. Periodontol 2000. 2022;89(1):154-165.
Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34(4):304-308.
Zhao H, Chu M, Huang Z, et al. Variations in oral microbiota associated with oral cancer. Sci Rep. 2017;7(1):11773.
Zhang L, Liu Y, Zheng HJ, Zhang CP. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol. 2019;9:476.
De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457-474.
Bronzato JD, Bomfim RA, Edwards DH, Crouch D, Hector MP, Gomes B. Detection of Fusobacterium in oral and head and neck cancer samples: a systematic review and meta-analysis. Arch Oral Biol. 2020;112:104669.
Guo ZC, Jumatai S, Jing SL, Hu LL, Jia XY, Gong ZC. Bioinformatics and immunohistochemistry analyses of expression levels and clinical significance of CXCL2 and TANs in an oral squamous cell carcinoma tumor microenvironment of Prophyromonas gingivalis infection. Oncol Lett. 2021;21(3):189.
Hooper SJ, Crean SJ, Fardy MJ, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2007;56(Pt 12):1651-1659.
Diaz PI, Zilm PS, Rogers AH. Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments. Microbiology. 2002;148(Pt 2):467-472.
Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci. 2011;3(4):209-215.
Hooper SJ, Crean SJ, Lewis MA, Spratt DA, Wade WG, Wilson MJ. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol. 2006;44(5):1719-1725.
Pushalkar S, Ji X, Li Y, et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 2012;12:144.
Schmidt BL, Kuczynski J, Bhattacharya A, et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS One. 2014;9(6):e98741.
Williams JM, Lawton C, Ellis SJ, Walsh S, Reed J. Copycat suicide attempts. Lancet. 1987;2(8550):102-103.
Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 2017;7(1):1834.
Perera M, Al-Hebshi NN, Perera I, et al. Inflammatory bacteriome and oral squamous cell carcinoma. J Dent Res. 2018;97(6):725-732.
Perera M, Al-Hebshi NN, Perera I, et al. A dysbiotic mycobiome dominated by Candida albicans is identified within oral squamous-cell carcinomas. J Oral Microbiol. 2017;9(1):1385369.
Yang K, Wang Y, Zhang S, et al. Oral microbiota analysis of tissue pairs and saliva samples from patients with oral squamous cell carcinoma - a pilot study. Front Microbiol. 2021;12:719601.
Yost S, Stashenko P, Choi Y, et al. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci. 2018;10(4):32.
Yamamura K, Baba Y, Nakagawa S, et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574-5581.
Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292-298.
Alon-Maimon T, Mandelboim O, Bachrach G. Fusobacterium nucleatum and cancer. Periodontol 2000. 2022;89(1):166-180.
Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-215.
Fardini Y, Wang X, Temoin S, et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011;82(6):1468-1480.
Casasanta MA, Yoo CC, Udayasuryan B, et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020;13(641):eaba9157.
Liu Z, Zhang Z, Zhang Y, et al. Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma. Int J Oral Sci. 2024;16(1):9.
Li T, Han L, Ma S, et al. Interaction of gut microbiota with the tumor microenvironment: a new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer. Front Mol Biosci. 2023;10:1140325.
Wang Q, Gao P, Wang X, Duan Y. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep. 2014;4:6802.
Sorsa T, Nwhator SO, Sakellari D, et al. aMMP-8 oral fluid PoC test in relation to oral and systemic diseases. Front Oral Health. 2022;3:897115.
Song X, Yang X, Narayanan R, et al. Oral squamous cell carcinoma diagnosed from saliva metabolic profiling. Proc Natl Acad Sci USA. 2020;117(28):16167-16173.
Riccardi G, Bellizzi MG, Fatuzzo I, et al. Salivary biomarkers in oral squamous cell carcinoma: a proteomic overview. Proteomes. 2022;10(4):37.
Nonaka T, Wong DTW. Liquid biopsy in head and neck cancer: promises and challenges. J Dent Res. 2018;97(6):701-708.
Keskin M, Lahteenmaki H, Rathnayake N, et al. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study. Expert Rev Proteomics. 2020;17(10):777-784.
Gleber-Netto FO, Yakob M, Li F, et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016;22(13):3340-3347.
Banavar G, Ogundijo O, Julian C, et al. Detecting salivary host and microbiome RNA signature for aiding diagnosis of oral and throat cancer. Oral Oncol. 2023;145:106480.
Rai AK, Panda M, Das AK, et al. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 2021;203(1):137-152.
Lee WH, Chen HM, Yang SF, et al. Bacterial alterations in salivary microbiota and their association in oral cancer. Sci Rep. 2017;7(1):16540.
Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget. 2016;7(32):51320-51334.
Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005;3:27.
Hsiao JR, Chang CC, Lee WT, et al. The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma. Carcinogenesis. 2018;39(6):778-787.
Guu SY, Lin TH, Chang SC, et al. Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients. PLoS One. 2017;12(6):e0178927.
Abdulla R, Devasia Puthenpurackal J, Pinto SM, Rekha PD, Subbannayya Y. Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker. Front Oncol. 2023;13:1167691.
Park DG, Woo BH, Lee BJ, et al. Serum levels of Interleukin-6 and titers of antibodies against Porphyromonas gingivalis could be potential biomarkers for the diagnosis of oral squamous cell carcinoma. Int J Mol Sci. 2019;20(11):2749.
Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33(5):1055-1058.
Manoil D, Courvoisier DS, Gilbert B, et al. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. Rheumatology. 2021;60(10):4755-4764.
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862-1880.
Baek K, Lee J, Lee A, et al. Characterization of intratissue bacterial communities and isolation of Escherichia coli from oral lichen planus lesions. Sci Rep. 2020;10(1):3495.
Hashibe M, Mathew B, Kuruvilla B, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev. 2000;9(7):639-645.
Shah N, Sharma PP. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): a case-control study. J Oral Pathol Med. 1998;27(10):475-479.
Munde A, Karle R. Proliferative verrucous leukoplakia: an update. J Cancer Res Ther. 2016;12(2):469-473.
Gonzalez-Moles MA, Warnakulasuriya S, Gonzalez-Ruiz I, et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2021;27(4):813-828.
Baraniya D, Chen T, Nahar A, et al. Supragingival mycobiome and inter-kingdom interactions in dental caries. J Oral Microbiol. 2020;12(1):1729305.
Diaz PI, Dongari-Bagtzoglou A. Critically appraising the significance of the oral mycobiome. J Dent Res. 2021;100(2):133-140.
Diaz PI. Subgingival fungi, archaea, and viruses under the omics loupe. Periodontol 2000. 2021;85(1):82-89.
Halwachs B, Madhusudhan N, Krause R, et al. Critical issues in mycobiota analysis. Front Microbiol. 2017;8:180.
Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713.
Dupuy AK, David MS, Li L, et al. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS One. 2014;9(3):e90899.
Abusleme L, Diaz PI, Freeman AF, et al. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis. JCI Insight. 2018;3(17):e122061.
Hong BY, Hoare A, Cardenas A, et al. The salivary mycobiome contains 2 ecologically distinct mycotypes. J Dent Res. 2020;99(6):730-738.
Kruger W, Vielreicher S, Kapitan M, Jacobsen ID, Niemiec MJ. Fungal-bacterial interactions in health and disease. Pathogens. 2019;8(2):70.
Heng W, Wang W, Dai T, et al. Oral bacteriome and mycobiome across stages of oral carcinogenesis. Microbiol Spectr. 2022;10(6):e0273722.
Trivanovic D, Pavelic K, Persuric Z. Fighting cancer with bacteria and their toxins. Int J Mol Sci. 2021;22(23):12980.
Baindara P, Mandal SM. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie. 2020;177:164-189.
Baraniya D, Jain V, Lucarelli R, et al. Screening of health-associated oral bacteria for anticancer properties in vitro. Front Cell Infect Microbiol. 2020;10:575656.
Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633-640.
Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539-555.
Hu X, Zhang Q, Hua H, Chen F. Changes in the salivary microbiota of oral leukoplakia and oral cancer. Oral Oncol. 2016;56:e6-e8.
Amer A, Galvin S, Healy CM, Moran GP. The microbiome of potentially malignant oral leukoplakia exhibits enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia species. Front Microbiol. 2017;8:2391.
Hernandez BY, Zhu X, Goodman MT, et al. Betel nut chewing, oral premalignant lesions, and the oral microbiome. PLoS One. 2017;12(2):e0172196.
Decsi G, Soki J, Pap B, et al. Chicken or the egg: microbial alterations in biopsy samples of patients with oral potentially malignant disorders. Pathol Oncol Res. 2019;25(3):1023-1033.
Hashimoto K, Shimizu D, Hirabayashi S, et al. Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia. J Investig Clin Dent. 2019;10(4):e12445.
Ganly I, Yang L, Giese RA, et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer. 2019;145(3):775-784.
Gopinath D, Kunnath Menon R, Chun Wie C, et al. Salivary bacterial shifts in oral leukoplakia resemble the dysbiotic oral cancer bacteriome. J Oral Microbiol. 2020;13(1):1857998.
Herreros-Pomares A, Llorens C, Soriano B, et al. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma. Oral Oncol. 2021;116:105191.
Choi YS, Kim Y, Yoon HJ, et al. The presence of bacteria within tissue provides insights into the pathogenesis of oral lichen planus. Sci Rep. 2016;6:29186.
Wang K, Lu W, Tu Q, et al. Preliminary analysis of salivary microbiome and their potential roles in oral lichen planus. Sci Rep. 2016;6:22943.
He Y, Gong D, Shi C, Shao F, Shi J, Fei J. Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus. Oral Dis. 2017;23(5):674-682.
Carvalho M, Cavalieri D, Do Nascimento S, et al. Cytokines levels and salivary microbiome play a potential role in oral lichen planus diagnosis. Sci Rep. 2019;9(1):18137.
Du GH, Wang YF, Chen JJ, Deng YW, Han XZ, Tang GY. Potential association between Fusobacterium nucleatum enrichment on oral mucosal surface and oral lichen planus. Oral Dis. 2020;26(1):122-130.
Hijazi K, Morrison RW, Mukhopadhya I, et al. Oral bacterial diversity is inversely correlated with mucosal inflammation. Oral Dis. 2020;26(7):1566-1575.
Wang X, Zhao Z, Tang N, et al. Microbial community analysis of saliva and biopsies in patients with oral lichen planus. Front Microbiol. 2020;11:629.
Yu FY, Wang QQ, Li M, et al. Dysbiosis of saliva microbiome in patients with oral lichen planus. BMC Microbiol. 2020;20(1):75.
Zhong EF, Chang A, Stucky A, et al. Genomic analysis of oral lichen planus and related oral microbiome pathogens. Pathogens. 2020;9(11):952.
Zheng SW, Xu P, Cai LT, et al. The presence of Prevotella melaninogenica within tissue and preliminary study on its role in the pathogenesis of oral lichen planus. Oral Dis. 2022;28(6):1580-1590.
Li S, Zhang Y, Yang Z, et al. Helicobacter pylori infection is correlated with the incidence of erosive oral lichen planus and the alteration of the oral microbiome composition. BMC Microbiol. 2021;21(1):122.
Chen J, Liu K, Sun X, Shi X, Zhao G, Yang Z. Microbiome landscape of lesions and adjacent normal mucosal areas in oral lichen planus patient. Front Microbiol. 2022;13:992065.
Wu J, Peters BA, Dominianni C, et al. Cigarette smoking and the oral microbiome in a large study of American adults. ISME J. 2016;10(10):2435-2446.
Yu G, Phillips S, Gail MH, et al. The effect of cigarette smoking on the oral and nasal microbiota. Microbiome. 2017;5(1):3.
Rodriguez-Rabassa M, Lopez P, Rodriguez-Santiago RE, et al. Cigarette smoking modulation of saliva microbial composition and cytokine levels. Int J Environ Res Public Health. 2018;15(11):2479.
Karabudak S, Ari O, Durmaz B, et al. Analysis of the effect of smoking on the buccal microbiome using next-generation sequencing technology. J Med Microbiol. 2019;68(8):1148-1158.
Al-Zyoud W, Hajjo R, Abu-Siniyeh A, Hajjaj S. Salivary microbiome and cigarette smoking: a first of its kind investigation in Jordan. Int J Environ Res Public Health. 2019;17(1):256.
Lin D, Hutchison KE, Portillo S, et al. Association between the oral microbiome and brain resting state connectivity in smokers. Neuroimage. 2019;200:121-131.
Yang Y, Zheng W, Cai QY, et al. Cigarette smoking and oral microbiota in low-income and African-American populations. J Epidemiol Community Health. 2019;73(12):1108-1115.
Beghini F, Renson A, Zolnik CP, et al. Tobacco exposure associated with oral microbiota oxygen utilization in the New York City Health and Nutrition Examination Study. Ann Epidemiol. 2019;34:18-25.e3.
Al Bataineh MT, Dash NR, Elkhazendar M, et al. Revealing oral microbiota composition and functionality associated with heavy cigarette smoking. J Transl Med. 2020;18(1):421.
Sato N, Kakuta M, Uchino E, et al. The relationship between cigarette smoking and the tongue microbiome in an East Asian population. J Oral Microbiol. 2020;12(1):1742527.
Sato N, Kakuta M, Hasegawa T, et al. Metagenomic analysis of bacterial species in tongue microbiome of current and never smokers. NPJ Biofilms Microbiomes. 2020;6(1):11.
Wirth R, Maroti G, Mihok R, et al. A case study of salivary microbiome in smokers and non-smokers in Hungary: analysis by shotgun metagenome sequencing. J Oral Microbiol. 2020;12(1):1773067.
Jia YJ, Liao Y, He YQ, et al. Association between oral microbiota and cigarette smoking in the Chinese population. Front Cell Infect Microbiol. 2021;11:658203.
Suzuki N, Nakano Y, Yoneda M, Hirofuji T, Hanioka T. The effects of cigarette smoking on the salivary and tongue microbiome. Clin Exp Dent Res. 2022;8(1):449-456.